Considering that irisin administration has been proposed as a potential therapeutic tool to treat obesity and diabetes [50] and thus may have implications for decreasing cardiovascular risk, our results are of potential clinical relevance. The gene discussed is FNDC5; the disease is obesity due to melanocortin 4 receptor deficiency.